Formation of Cadmium Sulfide and Zinc Sulfide Mixture in the Interlayer Space of Montmorillonite

Control of particle growth and enhancement of photoluminescence, adsorption efficiency, and photocatalytic activity for zinc sulfide and cadmium sulfide using CoAl-layered double hydroxide system

The fabrication of zinc sulfide (ZnS) and cadmium sulfide (CdS) hybrids was carried out by the sulfidization of Zn(II) or Cd(II) adsorbed in dodecylsulfate modified CoAl-layered double hydroxide through solid-liquid reaction. The TEM images showed the nanocrystals of ZnS (2.61 nm) or CdS (3.29 nm) orderly distributed on the nanosheets. The BET surface area of ZnS (1.13 m²/g) and CdS (0.78 m²/g) was largely improved by intercalating in the interlayer space of CoAl-layered double hydroxide system (15-20 m²/g). The spectroscopic observations further confirmed the formation of ZnS or CdS nanoparticles in the hybrid as the evidence of the blue-shifted absorption onset (39-44 nm), and the increase of the photoluminescence intensity (3-4 times) relative to those of bare ZnS and CdS. The nanohybrids could be applicable as the adsorbent and photocatalyst on purifying wastewater contaminated with Congo red dye. By the adsorptive removal, the hybrids exhibited the maximum adsorption capacity of 216-234 mg/g, resulting from the effect of CoAl-layered double hydroxide. In addition, the photocatalytic degradation was completely conducted by using CdS hybrid with the rate constant of 0.0115 min^-1, because the host-guest and/or guest-guest interactions promoted the greater optical performance, and adsorption and photocatalytic efficiencies.

Brimonidine-montmorillonite hybrid formulation for topical drug delivery to the eye

Brimonidine (BMD) is often prescribed as an eye drop to reduce the intraocular pressure (IOP) for glaucoma treatment. However, eye drops are limited by rapid clearance from the preocular surface, and hence a low ocular drug bioavailability. Therefore, in this study, we propose montmorillonite (MMT), as a delivery carrier, hybridized with BMD (BMD-MMT) for topical drug delivery to the eye. The BMD-MMT hybrid was prepared by intercalating the BMD molecules in the interlayer space of the MMT lattice via ion-exchange reaction; it was then formulated with polyvinyl alcohol (PVA) to produce a dry tablet (i.e., BMD-MMT@PVA). The BMD-MMT@PVA hybrid drug released BMD in a sustained manner for more than 5 h under in vitro conditions. When the hybrid drug was administered to rabbit eyes in vivo, 43% and 18.5% BMD-MMT still remained on the preocular surface for 10 and 60 min after administration, respectively. Thus, the BMD-MMT@PVA hybrid drug exhibited a prolonged decrease in IOP, that is, for 12 h, which was approximately two times longer than that observed with the commercially available BMD eye drop, Alphagan® P.

Preparation of quantum dots-montmorillonite nanocomposites with strong photoluminescence for light-emitting diodes

CdTe QDs/MMT-Na⁺ nanocomposites with promising optical properties are used as color convertors in commercial LEDs for the first time.